Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials

Ähnliche Einträge

• Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.
  von: Pathan, A, et al.
  Veröffentlicht: (2007)
• Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
  von: McShane, H, et al.
  Veröffentlicht: (2004)
• Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
  von: Whelan, K, et al.
  Veröffentlicht: (2009)
• Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.
  von: Fletcher, H, et al.
  Veröffentlicht: (2008)
• Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
  von: Mcshane, H, et al.
  Veröffentlicht: (2005)